Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses

NeuroImage

Volumn 63, Issue 2, 2012, Pages 936-946

  Toussaint, Paule Joanne ^a,b   Perlbarg, Vincent ^a,b   Bellec, Pierre ^b,d   Desarnaud, Serge ^c   Lacomblez, Lucette ^a,c   Doyon, Julien ^b,d   Habert, Marie Odile ^a,b,c   Benali, Habib ^a,b  

^a UPMC Univ Paris 06   (France)

^b Laboratoire International de Neuroimagerie et Mode lisation   (Canada)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Alzheimer's disease; Amnestic mild cognitive impairment; Exploratory data driven analysis; FDG PET; Independent component analysis; Support vector machine; Voxel based group analysis

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; FUNCTIONAL NEUROIMAGING; GLUCOSE METABOLISM; HUMAN; INDEPENDENT COMPONENT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; UNIVARIATE ANALYSIS; VOXEL BASED MORPHOMETRY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; EARLY DIAGNOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; NEURAL PATHWAYS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REST;

EID: 84866173660     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.03.091     Document Type: Article

References (74)

1. Aisen P.S., Petersen R.C., Donohue M.C., Gamst A., Raman R., Thomas R.G., Walter S., Trojanowski J.Q., Shaw L.M., Beckett L.A., Jack C.R., Jagust W., Toga A.W., Saykin A.J., Morris J.C., Green R.C., Weiner M.W., the ADNI Clinical core of the Alzheimer's Disease Neuroimaging Initiative: Progress and plans. Alzheimers Dement. 2010, 6:239-246.
2. Anchisi D., Borroni B., Franceschi M., Kerrouche N., Kalbe E., Beuthien-Beumann B., Kappa S., Lenz O., Ludecke S., Marcone A., Mielke R., Ortelli P., Padovani A., Pelati O., Pupi A., Scarpini E., Weisenbach S., Herholz K., Salmon E., Holthoff V., Sorbi S., Fazio F., Perani D. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch. Neurol. 2005, 62:1728-1733.
3. Andrews-Hanna J.R., Snyder A.Z., Vincent J.L., Lustig C., Head D., Raichle M.E., Buckner R.L. Disruption of large-scale brain systems in advanced aging. Neuron 2007, 56:924-937.
4. Bai F., Zhang Z., Yu H., Shi Y., Yuan Y., Zhu W., Zhang X., Qian Y. Default- mode network activity distinguishes amnestic type mild cognitive impairment from healthy aging: a combined structural and resting-state functional MRI study. Neurosci. Lett. 2008, 438:111-115.
5. Boser B.E., Guyon I.M., Vapnik V.N. A training algorithm for optimal margin classifiers. Proceedings of the Fifth Annual Workshop on Computational Learning Theory. COLT '92 1992, 144-152. ACM, New York.
6. Buchert R., Wilke F., Chakrabarti B., Martin B., Brenner W., Mester J., Clausen M. Adjusted scaling of FDG positron emission tomography images for statistical evaluation in patients with suspected Alzheimer's disease. J. Neuroimaging 2005, 15:348-355.
7. Chai J.W., Chi-Chang Chen C., Chiang C.M., Ho Y.J., Chen H.M., Ouyang Y.C., Yang C.W., Lee S.K., Chang C.I. Quantitative analysis in clinical applications of brain MRI using independent component analysis coupled with support vector machine. J. Magn. Reson. Imaging 2010, 32:24-34.
8. Chang C.C., Lin C.J. LIBSVM: A library for support vector machines. ACM Trans. Intell. Syst. Technol. 2011, 2:1-27.
9. Cortes C., Vapnik V. Support vector network. Mach. Learn. 1995, 20:273-297.
10. Damoiseaux J.S., Rombouts S.A., Barkhof F., Scheltens P., Stam C.J., Smith S.M., Beckmann C.F. Consistent resting-state networks across healthy subjects. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:13848-13853.
11. Desgranges B., Baron J.C., de la Sayette V., Petit-Taboué M.C., Benali K., Landeau B., Lechevalier B., Eustache F. The neural substrates of memory systems impairment in Alzheimer's disease: A PET study of resting brain glucose utilization. Brain 1998, 121:611-631.
12. Dubois B., Albert M.L. Amnestic MCI or prodromal Alzheimer's disease?. Lancet Neurol. 2004, 3:246-248.
13. Dubois B., Feldman H.H., Jacova C., Dekosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P.J., Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007, 6:734-746.
14. Dudkin K.N., Chueva I.V., Makarov F.N., Bich T.G., Roher A.E. Disorders of learning and memory processes in a monkey model of Alzheimer's disease: The role of the associative area of the cerebral cortex. Neurosci. Behav. Physiol. 2006, 36:789-799.
15. Duffy C.J. Visual motion processing in aging and Alzheimer's disease: Neuronal mechanisms and behavior from monkeys to man. Ann. N. Y. Acad. Sci. 2009, 1170:736-744.
16. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci. 2009, 32:548-557.
17. Fan Y., Resnick S.M., Wu X., Davatzikos C. Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study. NeuroImage 2008, 41:277-285.
18. Folstein M.F., Folstein S.E., McHugh P.R. Mini Mental State. J. Psychiatr. Res. 1975, 12:189-198.
19. Friston K.J., Frith C.D., Liddle P.F., Dolan R.J., Lammertsma A.A., Frackowiak R.S.J. The relationship between global and local changes in PET scans. J. Cereb. Blood Flow Metab. 1990, 10:458-466.
20. Ganguli M., Dodge H.H., DeKosky S.T. Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology 2004, 63:115-121.
21. Gispert J.D., Pascau J., Reig S., Martínez-Lázaro R., Molina V., García-Barreno P., Desco M. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans. Neuroimage 2003, 19:601-612.
22. Gorno-Tempini M.L., Dronkers N.F., Rankin K.P., Ogar J.M., Phengrasamy L., Rosen H.J., Johnson J.K., Weiner M.W., Miller B.L. Cognition and anatomy in three variants of primary progressive aphasia. Ann. Neurol. 2004, 55:335-346.
23. Greicius M.D., Srivastava G., Reiss A.L., Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI. Proc. Natl. Acad. Sci. 2004, 13:4637-4642.
24. Habeck C., Foster N.L., Perneczky R., Kurz A., Alexopoulos P., Koeppe R.A., Drzezga A., Stern Y. Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease. Neuroimage 2008, 40:1503-1515.
25. Habeck C., Stern Y. Multivariate data analysis for neuroimaging data: Overview and application to Alzheimer's disease. Cell Biochem. Biophys. 2010, 58:53-67.
26. Herholz K., Salmon E., Perani D., Baron J.C., Holthoff V., Frolich L., Schonknecht P., Ito K., Mielke R., Kalbe E., Zundorf G., Delbeuck X., Pelati O., Anchisi D., Fazio F., Kerrouche N., Desgranges B., Eustache F., Beuthien-Baumann B., Menzel C., Schroder J., Kato T., Arahata Y., Henze M., Heiss W.D. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002, 17:302-326.
27. Hyvärinen A., Karhunen J., Oja E. Independent component analysis 2001, Wiley, New York.
28. Jack C.R., Knopman D., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128.
29. Jagust W. Molecular imaging in Alzheimer's disease. NeuroRX 2004, 1:206-212.
30. Jagust W., Reed B., Mungas D., Ellis W., DeCarli C. What does fluorodeoxyglu- cose PET imaging add to a clinical diagnosis of dementia?. Neurology 2007, 69:871-877.
31. Jagust W.J., Bandy D., Chen K., Foster N.L., Landau S.M., Mathis C.A., Price J.C., Reiman E.M., Skovronsky D., Koeppe R.A., ADNI The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement. 2010, 6:221-229.
32. Joshi A., Koeppe R.A., Fessler J.A. Reducing between scanner differences in multi-center PET studies. Neuroimage 2009, 46:154-159.
33. 18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis. J. Cereb. Blood Flow Metab. 2006, 26:1213-1221.
34. Knopman D.S., DeKosky S.T., Cummings J.L., Chui H., Corey-Bloom J., Relkin N., Small G.W., Miller B., Stevens J.C. Practice parameter: diagnosis of de- mentia (an evidence-based review) report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1143-1153.
35. Koch W., Teipel S., Mueller S., Buerger K., Bokde A.L., Hampel H., Coates U., Reiser M., Meindl T. Effects of aging on default mode network activity in resting state fMRI: does the method of analysis matter?. Neuroimage 2010, 51:280-287.
36. Langbaum J.B.S., Chen K., Lee W., Reschke C., Bandy D., Fleisher A.S., Alexander G.E., Foster N.L., Weiner M.W., Koeppe R.A., Jagust W., Reiman E.M., the ADNI Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage 2009, 45:1107-1116.
37. Markiewicz P.J., Matthews J.C., Declerck J., Herholz K. Robustness of multivariate image analysis assessed by resampling techniques and applied to FDG-PET scans of patients with Alzheimer's disease. Neuroimage 2009, 46:472-485.
38. Markiewicz P.J., Matthews J.C., Declerck J., Herholz K. Robustness of correla- tions between PCA of FDG-PET scans and biological variables in healthy and demented subjects. Neuroimage 2011, 56:782-787.
39. Markiewicz P.J., Matthews J.C., Declerck J., Herholz K., Alzheimer's Disease Neuroimaging Initiative (ADNI) Verification of predicted robustness and accuracy of multivariate analysis. Neuroimage 2011, 56:1382-1385.
40. McKahnn G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
41. Miller S.L., Celone K., DePeau K., Diamond E., Dickerson B.C., Rentz D., Pihlajamäki M., Sperling R.A. Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. PNAS 2008, 105:2181-2186.
42. Minka T.P. Automatic choice of dimensionality for PCA. MLPCS 514, MIT Media Laboratory Perceptual Computing Section 2000, December.
43. Minoshima S., Koeppe R.A., Frey K.A., Kuhl D.E. Anatomic standardization: Linear scaling and nonlinear warping of functional brain images. J. Nucl. Med. 1994, 35:1528-1537.
44. Minoshima S., Giordani B., Berent S., Frey K.A., Foster N.L., Kuhl D.E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 1997, 42:85-94.
45. Morris J.C. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology 1993, 43:2412-2414.
46. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 2005, 32:486-510.
47. Mueller S.G., Weiner M.W., Thal L.J., Petersen R.C., Jack C.R., Jagust W.J., Trojanowski J.Q., Toga A.W., Beckett L. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2005, 1:55-66.
48. Müller N.G., Knight R.T. The functional neuroanatomy of working memory: Contributions of human brain lesion studies. Neuroscience 2006, 139:51-58.
49. Pandya D.N., Hoesen G.W.V., Mesulam M.M. Efferent connections of the cingulate gyrus in the rhesus monkey. Exp. Brain Res. 1981, 42:319-330.
50. Perlbarg V., Bellec P., Anton J.L., Pelegrini-Issac M., Doyon J., Benali H. CORSICA: correction of structured noise in fMRI by automatic identification of ICA components. Magn. Reson. Imaging 2007, 25:35-46.
51. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56:303-308.
52. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., DeKosky S.T. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Neurology 2001, 56:1133-1142.
53. Petersen R.C., Roberts R.O., Knopman D.S., Boeve B.F., Geda Y.E., Ivnik R.J., Smith G.E., Jack C.R. Mild cognitive impairment: ten years later. Arch. Neurol. 2009, 66:1447-1455.
54. Petersen R.C., Aisen P.S., Beckett L.A., Donohue M.C., Gamst A.C., Harvey D.J., Jack C.R., Jagust W.J., Shaw L.M., Toga A.W., Trojanowski J.Q., Weiner M.W. Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization. Neurology 2010, 74:201-209.
55. Pietrini P., Azari N.P., Grady C.L., Salerno J.A., Gonzales-Aviles A., Heston L.L., Pettigrew K.D., Horwitz B., Haxby J.V., Schapiro M.B. Pattern of cerebral metabolic interactions in a subject with isolated amnesia at risk for Alzheimer's disease: a longitudinal evaluation. Dementia 1993, 4:94-101.
56. Raji C.A., Becker J.T., Tsopelas N.D., Price J.C., Mathis C.A., Saxton J.A., Lopresti B.J., Hoge J.A., Ziolko S.K., DeKosky S.T., Klunk W.E. Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer's disease with Pittsburgh Compound B. J Neurosc Methods 2008, 172:277-282.
57. Ranganath C. Working memory for visual objects: complementary roles of inferior temporal, medial temporal, and prefrontal cortex. Neuroscience 2006, 139:277-289.
58. Rapoport S.I., Horwitz B., Grady C.L., Haxby J.V., DeCarli C., Schapiro M.B. Abnormal brain glucose metabolism in Alzheimer's disease, as measured by positron emission tomography. Adv. Exp. Med. Biol. 1991, 291:231-248.
59. Rizzo M., Nawrot M. Perception of movement and shape in Alzheimer's disease. Brain 1998, 121:2259-2270.
60. Rombouts S.A., Barkhof F., Goekoop R., Stam C.J., Scheltens P. Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: An fMRI study. Hum. Brain Mapp. 2005, 26:231-239.
61. Rombouts S.A., Damoiseaux J.S., Goekoop R., Barkhof F., Scheltens P., Smith S.M., Beckmann C.F. Model-free group analysis shows altered BOLD fMRI networks in dementia. Hum. Brain Mapp. 2009, 30:256-266.
62. Salas-Gonzalez D., Goórriz J.M., Ramírez J., Illan I.A., Lopez M., Segovia F., Chaves R., Padilla P., Puntonet C.G. Feature selection using factor analysis for Alzheimer's diagnosis using 18F-FDG PET images. Med. Phys. 2010, 37:6084-6095.
63. Sato J.R., Mourão-Miranda J., Martin M.G.M., Amaro E., Morettin P.A., Brammer M.J. The impact of functional connectivity changes on support vector machines mapping of fMRI data. J. Neurosci. Methods 2008, 172:94-104.
64. Scarmeas N., Habeck C.G., Zarahn E., Anderson K.E., Park A., Hilton J., Pelton G.H., Tabert M.H., Honig L.S., Moeller J.R., Devanand D.P., Stern Y. Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. Neuroimage 2004, 23:35-45.
65. Silverman S.E., Tran D.B., Zimmerman K.M., Feldon S.E. Dissociation between the detection and perception of motion in Alzheimer's disease. Neurology 1994, 44:1814-1818.
66. Smith S.M., Fox P.T., Miller K.L., Glahn D.C., Fox P.M., Mackay C.E., Filippini N., Watkins K.E., Toro R., Laird A.R., Beckmann C.F. Correspondence of the brain's functional architecture during activation and rest. Proc. Natl. Acad. Sci. 2009, 106:13040-13045.
67. Sorg C., Riedl V., Mühlau M., Calhoun V.D., Eichele T., Läer L., Drzezga A., Förstl H., Kurz A., Zimmer C., Wohlschläger A.M. Selective changes of resting-state networks in individuals at risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:18760-18765.
68. Sperling R.A., Laviolette P.S., O'Keefe K., O'Brien J., Rentz D.M., Pihlajamaki M., Marshall G., Hyman B.T., Selkoe D.J., Hedden T., Buckner R.L., Becker J.A., Johnson K.A. Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron 2009, 63:178-188.
69. Squire L.R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 1999, 99:195-231.
70. Tetewsky S., Duffy C.J. Visual loss and getting lost in Alzheimer's disease. Neurology 1999, 52:958-965.
71. Vapnik V. The nature of statistical learning theory 1995, Springer-Verlag, New York.
72. Vincent J.L., Snyder A.Z., Fox M.D., Shannon B.J., Andrews J.R., Raichle M.E., Buckner R.L. Coherent spontaneous activity identifies a hippocampal-parietal memory network. J. Neurophysiol. 2006, 96:3517-3531.
73. Zhang D., Wang Y., Zhou L., Yuan H., Shen D., Alzheimer's Disease Neuroimaging Initiative Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage 2011, 55:856-867.
74. Zhou J., Greicius M.D., Gennatas E.D., Growdon M.E., Jang J.Y., Rabinovici G.D., Kramer J.H., Weiner M., Miller B.L., Seeley W.W. Divergent network con- nectivity changes in behavioral variant frontotemporal dementia and Alzheimer's disease. Brain 2010, 133:1352-1367.